1. Market Research
  2. > Pharmaceutical Market Trends
  3. > South Africa Pharmaceuticals and Healthcare Report Q2 2016

South Africa Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 113 pages

Includes 3 FREE quarterly updates

Headline Expenditure Projections

- Pharmaceuticals: ZAR43.41bn (USD3.42bn) in 2015 to ZAR47.33bn (USD2.91bn) in 2016; +9.0% inlocal currency terms and -14.7% in US dollar terms. Forecast in US dollar terms revised downwardsfrom last quarter.- Healthcare: ZAR351.1bn (USD27.6bn) in 2015 to ZAR378.7bn (USD23.3bn) in 2016; +7.9% in localcurrency terms and -15.7% in US dollar terms. Forecast in US dollar terms revised downwards from lastquarter.

Table Of Contents

South Africa Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (South Africa 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (South Africa 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (South Africa 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (South Africa 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (South Africa 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (South Africa 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (South Africa 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (South Africa 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (South Africa 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (South Africa 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (South Africa 2014-2020) 28
Industry Risk/Reward Index 29
Middle East and Africa Risk/Reward Index - Q2 2016 29
South Africa Risk/Reward Index 36
Rewards 36
Risks 37
Regulatory Review 38
Table: Drug Classification System 38
Intellectual Property Issues 43
Pricing Regime 46
Table: Tiered Pharmaceutical Pricing System Is Better Than A Flat Fixed Mark-Up 46
Reimbursement Regime 48
Market Overview 49
Healthcare Sector 51
Table: Healthcare Resources (South Africa 2010-2015) 57
Table: Healthcare Personnel (South Africa 2010-2015) 57
Table: Healthcare Activity (South Africa 2010-2015) 58
Research and Development 58
Clinical Trials 59
Epidemiology 63
Competitive Landscape 67
Research-Based Industry 67
Table: Multinational Market Activity 69
Generic Drugmakers 70
Pharmaceutical Retail Sector 71
Company Profile 75
Aspen Pharmacare 75
Adcock Ingram 79
Cipla Medpro 84
GlaxoSmithKline 88
Novartis 92
Pfizer 94
Roche 97
Sanofi 99
Demographic Forecast 102
Demographic Outlook 102
Table: Population Headline Indicators (South Africa 1990-2025) 103
Table: Key Population Ratios (South Africa 1990-2025) 103
Table: Urban/Rural Population and Life Expectancy (South Africa 1990-2025) 104
Table: Population By Age Group (South Africa 1990-2025) 104
Table: Population By Age Group % (South Africa 1990-2025) 105
Glossary 107
Methodology 109
Pharmaceutical Expenditure Forecast Model 109
Healthcare Expenditure Forecast Model 109
Notes On Methodology 110
Risk/Reward Index Methodology 111
Index Overview 112
Table: Pharmaceutical Risk/Reward Index Indicators 112
Indicator Weightings 113

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.